Prudential Financial
COGT icon

Prudential Financial’s Cogent Biosciences COGT Stock Holding History

Prudential Financial’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.86M Buy
178,165
+57,990
+48% +$2.14M 0.01% 781
2025
Q4 		$4.27M Buy
120,175
+104,780
+681% +$2.95M 0.01% 990
2025
Q3 		$221K Buy
15,395
+2,490
+19% +$29.5K ﹤0.01% 2192
2025
Q2 		$92.7K Buy
+12,905
New +$71.5K ﹤0.01% 2295

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Prudential Financial's COGT Position: Q1 2026 in Review

Prudential Financial increased its Cogent Biosciences (COGT) stake by 48% in Q1 2026, buying an estimated $2.14M and bringing the position to 178,165 shares worth $6.86M. The position accounts for 0.01% of the portfolio, ranked #781.

Prudential Financial first reported a position in COGT in Q2 2025 and has held it in 4 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Prudential Financial held 178,165 shares of Cogent Biosciences worth $6.86M as of Q1 2026.
  • Prudential Financial bought 57,990 Cogent Biosciences shares in Q1 2026, an estimated $2.14M.
  • Cogent Biosciences made up 0.01% of Prudential Financial's portfolio in Q1 2026, its #781 holding.
  • Prudential Financial first reported a position in Cogent Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.